Haemonetics Corp (HAE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 348,542 | 345,511 | 336,172 | 343,290 | 336,250 |
| Cost of Goods | 154,995 | 158,074 | 161,248 | 167,384 | 158,383 |
| Gross Profit | 193,547 | 187,437 | 174,924 | 175,906 | 177,867 |
| Operating Expenses | 135,513 | 135,814 | 135,416 | 146,347 | 132,272 |
| Operating Income | 59,029 | 51,697 | 39,756 | 29,943 | 45,978 |
| Interest Expense | 9,112 | 6,993 | -6,957 | 8,598 | 1,949 |
| Other Income | 0 | 0 | 0 | 2,069 | 0 |
| Pre-tax Income | 49,917 | 44,704 | 46,713 | 23,414 | 44,029 |
| Income Tax | 12,423 | 10,873 | 8,340 | 3,047 | 12,788 |
| Net Income Continuous | 37,494 | 33,831 | 38,373 | 20,367 | 31,241 |
| Net Income | $37,494 | $33,831 | $38,373 | $20,367 | $31,241 |
| EPS Basic Total Ops | 0.75 | 0.66 | 0.75 | 0.40 | 0.62 |
| EPS Basic Continuous Ops | 0.75 | 0.66 | 0.75 | 0.40 | 0.62 |
| EPS Diluted Total Ops | 0.74 | 0.66 | 0.74 | 0.40 | 0.61 |
| EPS Diluted Continuous Ops | 0.74 | 0.66 | 0.74 | 0.40 | 0.61 |
| EPS Diluted Before Non-Recurring Items | 1.19 | 1.12 | 1.02 | N/A | N/A |
| EBITDA(a) | $91,395 | $84,653 | $74,131 | $60,929 | $69,509 |